Person:
SALMAN, ANDAÇ

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

SALMAN

First Name

ANDAÇ

Name

Filters

2015 - 202016
Reset filters

Settings

Author: ERGUN, SAFİYE ATLAS TÜLİN ×

Search Results

Now showing 1 - 10 of 17
  • Thumbnail Image
    PublicationOpen Access
    Nodular mucinosis of the breast: A rare entity
    (MARMARA UNIV, FAC MEDICINE, 2018-06-05) SALMAN, ANDAÇ; Salman, Andac; Cinel, Leyla; Turkoz, Huseyin Kemal; Akbas, Gamze; Ergun, Tulin
    Nodular mucinosis of the breast (NMB) is an uncommon disease involving the nipple-areolar region. It usually presents with asymptomatic, subcutaneous masses with indolent growth in women. Here, we report a 43-year-old man presented with a subcutaneous growth on the left nipple. Histopathological examination confirmed the diagnosis of NMB. We report our patient in order to point out this rare disease and think that the recognition of this entity is important for both clinicians and pathologists.
  • No Thumbnail Available
    PublicationMetadata only
    Autoimmune progesterone dermatitis mimicking fixed drug eruption
    (2017) SALMAN, ANDAÇ; Salman, Andac; Ergun, Tulin
  • No Thumbnail Available
    PublicationMetadata only
    Expanding the differential diagnosis of raccoon eyes: sweet syndrome
    (2019) SALMAN, ANDAÇ; Salman, A.; Demir, G.; Cinel, L.; Oguzsoy, T.; Yıldızhan, G.; Ergun, T.
  • No Thumbnail Available
    PublicationMetadata only
    Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream
    (WILEY, 2017) SALMAN, ANDAÇ; Salman, Andac; Sarac, Gonca; Kuru, Burce Can; Cinel, Leyla; Yucelten, Ayse Deniz; Ergun, Tulin
    Acquired progressive lymphangioma (APL), or benign lymphangioendothelioma, is an unusual entity derived from vascular structures. Clinically and histopathologically it may resemble Kaposi's sarcoma and well-differentiated angiosarcoma, causing a diagnostic problem. We report an individual with APL initially diagnosed with Kaposi's sarcoma who underwent unnecessary laboratory testing. Imiquimod 5% cream stopped the progression of the lesion. Awareness of this rare entity may prevent patients from undergoing excessive testing. Imiquimod may be used as a safe, effective treatment option.
  • Thumbnail Image
    PublicationOpen Access
    Atypical presentations of eosinophilic fasciitis
    (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2016) SALMAN, ANDAÇ; Ergun, Tulin; Seckin, Dilek; Salman, Andac; Ocak, Esra Sarac; Yucelten, Ayse Deniz; Direskeneli, Haner; Demirkesen, Cuyan; Ekinci, Gazanfer; Bayik, Mahmut
    Eosinophilic fasciitis is an uncommon connective tissue disease that may mimic and overlap with other sclerosing disorders such as morphea and lichen sclerosus. Herein, we report four patients (two men and two women, aged 16-64 yeas) with eosinophilic fasciitis. There was overlap with both morphea and lichen sclerosus in 2 patients and with morphoea alone in 1 patient. Magnetic resonance imaging (MRI) was used for diagnosis in three patients and for assessing treatment response in one patient. Eosinophilic fasciitis may co-exist with morhoea and lichen sclerosus. In view of the overlapping clinical and histopathological features of these disorders, MRI may be helful in delineating the conditions by detecting involvement of fascia.
  • Thumbnail Image
    PublicationOpen Access
    Cutaneous leishmaniasis mimicking verrucous carcinoma: A case with an unusual clinical course
    (WOLTERS KLUWER MEDKNOW PUBLICATIONS, 2015) SALMAN, ANDAÇ; Salman, Andac; Yucelten, Ayse Deniz; Seckin, Dilek; Ergun, Tulin; Demircay, Zeynep
  • Thumbnail Image
    PublicationOpen Access
    Tumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis: A report of four cases with a literature review
    (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2017) SALMAN, ANDAÇ; Ergun, Tulin; Seckin-Gencosmanoglu, Dilek; Salman, Andac; Qzgen, Zuleyha; Ocak, Esra Sarac; Avsar, Erol; Imeryuz, Nese
    Patients with psoriasis are at an increased risk of developing liver disease due to various factors. The existing data regarding the treatment of psoriasis patients with associated liver cirrhosis is limited. We report four patients of psoriasis with liver cirrhosis who were treated with TNF-alpha inhibitors for a mean duration of 35.4 months. Two patients were treated with etanercept, one with adalimumab and one was treated with both infliximab and etanercept. Three patients tolerated the treatment well without any deterioration of liver disease whereas one died of progressive liver disease. Although large-scale, controlled studies are needed, this case series provides insights regarding the long-term safety of TNF-alpha inhibitors in patients with psoriasis and liver cirrhosis.
  • No Thumbnail Available
    PublicationMetadata only
    Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis
    (2017) SALMAN, ANDAÇ; Salman, Andac; Sonmez, Yaman; Sahin, Hulya; Unal, Ali Ugur; Direskeneli, Haner; Cinel, Leyla; Ergun, Tulin
  • Thumbnail Image
    PublicationOpen Access
    Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study
    (TAYLOR & FRANCIS LTD, 2020-02-17) SALMAN, ANDAÇ; Salman, Andac; Ergun, Tulin; Maria Gimenez-Arnau, Ana
    Background: The real-life data on the effectiveness and safety of omalizumab in chronic spontaneous urticaria (CSU) with validated methods are scarce. There is also a lack of information on the use of combination treatments. Methods: A retrospective cohort study was done to evaluate the effectiveness and safety of omalizumab in real-life conditions. The patients with CSU treated with omalizumab between 2015 and 2018 were included. The response to therapy was evaluated using urticaria activity score over 7 days (UAS7) and urticaria control test (UCT). Results: A total of 106 patients were included. A complete response (CR) (UAS7:0) and a well-controlled activity (WCA) (UAS7:1 to <6) were observed in 50 (47.2%) and 35 (33%) patients, respectively. The number of patients with an UCT score >= 12 was also significantly increased. Higher rates of CR/WCA were observed with omalizumab monotherapy compared to combination with antihistamines. The combination of dapsone, colchicine, and omalizumab provided additional benefit in a small group. Conclusion: Treatment with omalizumab provided a rapid and sustainable improvement in real-life settings. The use of omalizumab as monotherapy or combined with antihistamines does not show differences in the treatment response. The combination of omalizumab with immunomodulatory agents might be of benefit in selected cases.
  • Thumbnail Image
    PublicationOpen Access
    Unilateral cutaneous vasculitis: An uncommon presentation and a possible explanation
    (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2015) SALMAN, ANDAÇ; Tekin, Burak; Salman, Andac; Tuglular, Serhan; Guler, Derya; Ozen, Gulsen; Direskeneil, Haner; Ayranci, Fatma Guicicek; Cinel, Leyla; Ergun, Tulln